In type 1 diabetes, the immune system starts to destroy insulin-producing beta cells in the pancreas. Progressive loss of these cells destabilizes the body's glucose levels and drives the course of ...
BATON ROUGE, La. ( Louisiana First) — Neuty, a 5-year-old pet nutria living in New Orleans, has cancer. His owners are asking for prayers. Myra Lacoste, is one of the owners of “Neuty,” along with her ...
However, definitive diagnosis evaded him, "We didn't go out and get a PET scan or a spinal tap, which would actually reveal if you actually have the plaques, because those tests were not covered by my ...
Clarity Pharmaceuticals (ASX: CU6) (Clarity or Company), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients ...
In recent years, a drug called ketamine has attracted attention because it can reduce depressive symptoms very quickly. Unlike traditional antidepressants, which may take weeks to work, ketamine can ...
FDA approves Pylarify TruVu, a new prostate cancer PET imaging agent designed to expand access and improve detection of recurrent or metastatic disease.
Construction and development specialist Seddon has completed enabling work to support the installation of UK-first Siemens Healthineers cancer imaging technology at a site on the Wirral.
Manufacturing optimization is projected to expand batch output by ~50%, improving supply reliability and supporting higher-throughput PSMA PET imaging services. Increased radioactivity extends shelf ...
Noozhawk republishes news articles from KFF Health News on national and state health-related issues that affect Santa Barbara County readers. Samantha ...
Major depressive disorder (MDD) is one of the leading causes of disability worldwide, and approximately 30% of patients develop treatment-resistant depression (TRD), a condition that does not respond ...
RadNet's management reported record Q4 2025 revenue, while underlying organic growth of the base imaging business is still healthy. See why RDNT stock is a strong buy.
The FDA has approved a new formulation of an F 18 prostate-specific membrane antigen imaging agent for men with prostate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results